Felipe Lott, MD
Financial relationships
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:msdMitigation strategy:AttestDate reviewed:07/25/2023
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:AstrazenecaMitigation strategy:AttestDate reviewed:07/25/2023
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:JanssenMitigation strategy:AttestDate reviewed:07/25/2023
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:bayerMitigation strategy:AttestDate reviewed:07/25/2023
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:AtsellasMitigation strategy:AttestDate reviewed:07/25/2023